Immunoprecise Antibodies Ltd IPA

ImmunoPrecise Reports Financial Results and Recent Business

[AveragePenny]

Fiscal 2022 Financial Summary*

• The Company achieved record total revenues of $19.4 million during the year ended April 30, 2022, an 8.1% increase from the year ended April 30, 2021.
• Project revenue of $17.4 million was $1.4 million, or 9.1%, higher than last year. Growth is driven primarily by the Company’s B cell Select® platform, with expansion in both the number and size of projects under contract.
• The Company, primarily through its subsidiary Talem Therapeutics LLC, invested $6.7 million in strategic research and development costs as compared to $2.0 million in 2021.
• The Company recorded a net loss of $16.7 million during the year ended April 30, 2022, compared to a net loss of $7.3 million for the year ended April 30, 2021.
• As of April 30, 2022, the Company held cash of $30 million (April 30, 2021 – $41.8 million)

https://www.businesswire.com/news/home/20220729005234/en/ImmunoPrecise-Reports-Financial-Results-and-Recent-Business-Highlights-for-Full-Fiscal-Year-2022

[GoldenArm]

Something is up here. There has been buying for the last 5 days. If the company has news they should release it now. Can someone see if this is insider buying? I would do it but I'm swamped at work.

[mercedesman]

Steady Insider buying since the start of 2022. Bath has more tripled her position since Dec 31 2021. Lots of other (smaller) buys from other Officers & Directors. I doubt there is NEWS that is ready to release.  Lots of ongoing discussions with Big companies to buy their candidates. From Conference Call "Is it reasonable to think one or more assets from the pipeline could be

[GoldenArm]

100% agree on that on big sale of Tatx going to phase 3. Don't know if this is all insider buying but can't say it it is not. Volume is up big time today.

[mercedesman]

Actually volume has fallen off a cliff in the past year or so...and remains light. Insider accumulation has been non-stop for most of the past year. As some deals from their pipeline come to fruitition & close...watch the volume start to sky-rocket...along with the share price. This one is about ready to come out of the oven and serve.  Anytime. MM